VivosStrong bargain investments are becoming harder to find in the bull market, but there are still picks available for investors who look closely in some surprising areas. The medical technology market is ready for expansion with small and innovative companies offering bargain stocks. Vivos Therapeutics Inc. (NASDAQ: VVOS) develops low-cost non-pharmaceutical solutions for sleep disorders and has had success with its therapies for obstructive sleep apnea.

In the 2019 fiscal year, Vivos saw an increase of 200.43% in sales, contributing to a gross profit margin of 69.39%. Revenue increased a further 34.9% over 2020 and is expected to increase another 33.04% in the current year. Analysts are optimistic that the strong revenue growth will lead to increased investor activity and a boost in the stock price.

The average target of $12.00 suggests a strong upside for investors who buy today. Whether purchasing this stock for short-term gains or as a long-term holding in medical technology, there are very few better bargain options on the market.

Key Data:

  • YTD Price Growth: 93%
  • 3 Month Price Growth: -6.50%
  • 5 Day Price Growth: 76%

All information is based on current and historical market data, as well as publicly available financial data. As with any financial decision, your own research is important. Stock market outcomes can never be 100% accurately predicted. Familiarity with historical data, individual industries, and individual stocks is key to developing a robust portfolio. Note that stock prices can fluctuate rapidly during trading sessions.